The Trustees Of Columbia University In The City Of New York

UEI QHF5ZZ114M72 · NY · SAM.gov record ↗

$-1.8M

FY2025 obligations

Contract awards

Sep 27, 2007

First action

Jun 25, 2026

Latest action

Obligations by agency

Department Of State$190K
National Aeronautics And Space Administration$0
Department Of Defense$-239K
Department Of Health And Human Services$-580K
Department Of Veterans Affairs$-1.1M

Obligations by NAICS

Monthly obligations

Oct 24

Nov 24

Dec 24

Jan 25

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Sep 25

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Apr 26

May 26

Jun 26

Contracts ending within 18 months (recompete watch)

75D30123F00001 ↗$56K
2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ
Ends
Sep 26, 2026
Started
Sep 27, 2023
Agency
Centers For Disease Control And Prevention
NAICS
622110
80ARC023CA004 ↗$0
CONTRACT FOR RESEARCH AND DEVELOPMENT WORK TO EXTEND LONGEVITY OF 3D TISSUES AND MICROPHYSIOLOGICAL SYSTEMS FOR MODELING OF ACUTE AND CHRONIC EXPOSURES TO STRESSORS.
Ends
Oct 30, 2026
Started
Oct 31, 2022
Agency
National Aeronautics And Space Administration
NAICS
541715
75N92026F00001 ↗$437K
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - FIELD CENTER (FC) - TASK AREA A
Ends
Dec 17, 2026
Started
Feb 12, 2026
Agency
National Institutes Of Health
NAICS
541715
75D30124F00002 ↗$0
CISA RSV INFANTS STUDY (CONTRIBUTING SITE)
Ends
Sep 25, 2027
Started
Sep 26, 2024
Agency
Centers For Disease Control And Prevention
NAICS
622110
75F40124C00081 ↗$-813K
CDER NEURODEVELOPMENTAL AND MENTAL HEALTH OUTCOMES IN PRETERM INFANTS: EFFECTS OF EXP
Ends
Sep 28, 2027
Started
Sep 15, 2024
Agency
Food And Drug Administration
NAICS
541714
75N94025F00001 ↗$540K
NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: NON-SEVERABLE
Ends
Dec 30, 2027
Started
Sep 28, 2025
Agency
National Institutes Of Health
NAICS
541714

PIID	Description	Agency	NAICS	Obligated	Start	End
75D30123F00001 ↗	2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ	Centers For Disease Control And Prevention	622110	$56K	Sep 27, 2023	Sep 26, 2026
80ARC023CA004 ↗	CONTRACT FOR RESEARCH AND DEVELOPMENT WORK TO EXTEND LONGEVITY OF 3D TISSUES AND MICROPHYSIOLOGICAL SYSTEMS FOR MODELING OF ACUTE AND CHRONIC EXPOSURES TO STRESSORS.	National Aeronautics And Space Administration	541715	$0	Oct 31, 2022	Oct 30, 2026
75N92026F00001 ↗	MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - FIELD CENTER (FC) - TASK AREA A	National Institutes Of Health	541715	$437K	Feb 12, 2026	Dec 17, 2026
75D30124F00002 ↗	CISA RSV INFANTS STUDY (CONTRIBUTING SITE)	Centers For Disease Control And Prevention	622110	$0	Sep 26, 2024	Sep 25, 2027
75F40124C00081 ↗	CDER NEURODEVELOPMENTAL AND MENTAL HEALTH OUTCOMES IN PRETERM INFANTS: EFFECTS OF EXP	Food And Drug Administration	541714	$-813K	Sep 15, 2024	Sep 28, 2027
75N94025F00001 ↗	NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: NON-SEVERABLE	National Institutes Of Health	541714	$540K	Sep 28, 2025	Dec 30, 2027

Largest awards

75N94025F00001 ↗$540K
NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: NON-SEVERABLE
Ends
Dec 30, 2027
Started
Sep 28, 2025
Agency
National Institutes Of Health
NAICS
541714
75N92026F00001 ↗$437K
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - FIELD CENTER (FC) - TASK AREA A
Ends
Dec 17, 2026
Started
Feb 12, 2026
Agency
National Institutes Of Health
NAICS
541715
19VM3025P0594 ↗$190K
HANOINAMRU-IP_VIRCAPSEQ-VERT PROBE SET AND TWIST REAGENTS
Ends
Sep 28, 2025
Started
Jul 26, 2025
Agency
Department Of State
NAICS
541380
75N92025F00001 ↗$186K
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), FIELD CENTER (FC): TASK AREA A - CORE OPERATIONS
Ends
Apr 10, 2025
Started
Dec 18, 2024
Agency
National Institutes Of Health
NAICS
541715
75D30123F00001 ↗$56K
2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ
Ends
Sep 26, 2026
Started
Sep 27, 2023
Agency
Centers For Disease Control And Prevention
NAICS
622110
75N94018F00005 ↗$5K
EOI::DEFEND THE SPEND::EOI TERMINATION FOR CONVENIENCE AGREEMENT
Ends
Jul 13, 2026
Started
Sep 24, 2018
Agency
National Institutes Of Health
NAICS
541712
75N94020D00013 ↗$0
EOI::DEFEND THE SPEND::EOI NOTICE OF TERMINATION FOR CONVENIENCE
Ends
—
Started
Jul 30, 2020
Agency
National Institutes Of Health
NAICS
541714
75F40124F19003 ↗$0
EOI::COLUMBIAU:: EOI NOTICE OF TERMINATION FOR CONVENIENCE (COMPLETE)
Ends
Mar 6, 2025
Started
Sep 25, 2024
Agency
Food And Drug Administration
NAICS
611710
75F40121F19002 ↗$0
EOI::COLUMBIAU:: EOI NOTICE OF TERMINATION FOR CONVENIENCE (COMPLETE)
Ends
Mar 6, 2025
Started
Sep 26, 2021
Agency
Food And Drug Administration
NAICS
611710
75N94023F00001 ↗$0
EOI::DEFEND THE SPEND::EOI TERMINATION FOR CONVENIENCE AGREEMENT
Ends
Mar 27, 2025
Started
Sep 27, 2023
Agency
National Institutes Of Health
NAICS
541714
75D30124P18698 ↗$0
EOI::EO 14222 - IMPLEMENTING THE PRESIDENT'S DOGE COST EFFICIENCY INITIATIVE::EOI NOTICE OF TERMINATION FOR CONVENIENCE
Ends
Jun 29, 2025
Started
Apr 23, 2024
Agency
Centers For Disease Control And Prevention
NAICS
541720
75F40119C10101 ↗$0
BAA FOR NEURODEVELOPMENTAL OUTCOMES IN INFANTS RECEIVING OPIOID-REPLACEMENT PHARMACOTHERAPY FOR NEONATAL OPIOID WITHDRAWAL SYNDROME(NOWS), REFERENCE: BAA- EETWP#31.
Ends
Aug 6, 2025
Started
Sep 20, 2019
Agency
Food And Drug Administration
NAICS
541715
75N93024P01130 ↗$0
EOI::DEFEND THE SPEND::EOI NOTICE OF TERMINATION FOR CONVENIENCE
Ends
Sep 14, 2025
Started
Sep 15, 2024
Agency
National Institutes Of Health
NAICS
541380
75D30122F00007 ↗$0
EOI::EO 14222 - IMPLEMENTING THE PRESIDENT'S DOGE COST EFFICIENCY INITIATIVE::EOI NOTICE OF TERMINATION FOR CONVENIENCE
Ends
Dec 27, 2025
Started
Sep 28, 2022
Agency
Centers For Disease Control And Prevention
NAICS
621399
75N92024F00001 ↗$0
REDS-IV-P DOMESTIC HUBS
Ends
Jun 29, 2026
Started
Jun 30, 2024
Agency
National Institutes Of Health
NAICS
541715
80ARC023CA004 ↗$0
CONTRACT FOR RESEARCH AND DEVELOPMENT WORK TO EXTEND LONGEVITY OF 3D TISSUES AND MICROPHYSIOLOGICAL SYSTEMS FOR MODELING OF ACUTE AND CHRONIC EXPOSURES TO STRESSORS.
Ends
Oct 30, 2026
Started
Oct 31, 2022
Agency
National Aeronautics And Space Administration
NAICS
541715
75D30124F00002 ↗$0
CISA RSV INFANTS STUDY (CONTRIBUTING SITE)
Ends
Sep 25, 2027
Started
Sep 26, 2024
Agency
Centers For Disease Control And Prevention
NAICS
622110
75F40120D00039 ↗$0
EOI::{HHS COST EFFICIENCY INITIATIVE}::EOI. NOTICE OF TERMINATION FOR CONVENIENCE (COMPLETE)
Ends
—
Started
Sep 29, 2020
Agency
Food And Drug Administration
NAICS
611710
75N92019D00037 ↗$0
EO14042 REDS-IV-P DOMESTIC HUBS
Ends
—
Started
Mar 31, 2019
Agency
National Institutes Of Health
NAICS
541715
75N92020D00002 ↗$0
EOI::DEFEND THE SPEND::EOI NOTICE OF TERMINATION FOR CONVENIENCE
Ends
—
Started
Dec 18, 2019
Agency
National Institutes Of Health
NAICS
541715
75N92026D00002 ↗$0
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - FIELD CENTER (FC)
Ends
—
Started
Feb 12, 2026
Agency
National Institutes Of Health
NAICS
541715
HHSD200200723654C ↗$0
KENYA HIV CARE AND TREATMENT
Ends
Sep 25, 2012
Started
Sep 27, 2007
Agency
Centers For Disease Control And Prevention
NAICS
923120
75N93023C00041 ↗$0
EOI::DEFEND THE SPEND::EOI NOTICE OF TERMINATION FOR CONVENIENCE
Ends
Mar 6, 2025
Started
Sep 29, 2023
Agency
National Institutes Of Health
NAICS
541512
75N93020C00059 ↗$-0
TO DEOBLIGATE FY 2020 5TH YEAR FUNDS CHARACTERIZING AND IMPROVING HUMANIZED IMMUNE SYSTEM MOUSE MODELS (IMM-HIS)
Ends
Sep 28, 2024
Started
Sep 29, 2020
Agency
National Institutes Of Health
NAICS
541715
75N92021F00001 ↗$-0
FY26 UDO INITIATIVE - MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) FIELD CENTER (FC) - TASK AREA B EXAM 7
Ends
Mar 28, 2024
Started
May 18, 2021
Agency
National Institutes Of Health
NAICS
541715

PIID	Description	Agency	NAICS	Obligated	Start	End
75N94025F00001 ↗	NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: NON-SEVERABLE	National Institutes Of Health	541714	$540K	Sep 28, 2025	Dec 30, 2027
75N92026F00001 ↗	MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - FIELD CENTER (FC) - TASK AREA A	National Institutes Of Health	541715	$437K	Feb 12, 2026	Dec 17, 2026
19VM3025P0594 ↗	HANOINAMRU-IP_VIRCAPSEQ-VERT PROBE SET AND TWIST REAGENTS	Department Of State	541380	$190K	Jul 26, 2025	Sep 28, 2025
75N92025F00001 ↗	MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), FIELD CENTER (FC): TASK AREA A - CORE OPERATIONS	National Institutes Of Health	541715	$186K	Dec 18, 2024	Apr 10, 2025
75D30123F00001 ↗	2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ	Centers For Disease Control And Prevention	622110	$56K	Sep 27, 2023	Sep 26, 2026
75N94018F00005 ↗	EOI::DEFEND THE SPEND::EOI TERMINATION FOR CONVENIENCE AGREEMENT	National Institutes Of Health	541712	$5K	Sep 24, 2018	Jul 13, 2026
75N94020D00013 ↗	EOI::DEFEND THE SPEND::EOI NOTICE OF TERMINATION FOR CONVENIENCE	National Institutes Of Health	541714	$0	Jul 30, 2020	—
75F40124F19003 ↗	EOI::COLUMBIAU:: EOI NOTICE OF TERMINATION FOR CONVENIENCE (COMPLETE)	Food And Drug Administration	611710	$0	Sep 25, 2024	Mar 6, 2025
75F40121F19002 ↗	EOI::COLUMBIAU:: EOI NOTICE OF TERMINATION FOR CONVENIENCE (COMPLETE)	Food And Drug Administration	611710	$0	Sep 26, 2021	Mar 6, 2025
75N94023F00001 ↗	EOI::DEFEND THE SPEND::EOI TERMINATION FOR CONVENIENCE AGREEMENT	National Institutes Of Health	541714	$0	Sep 27, 2023	Mar 27, 2025
75D30124P18698 ↗	EOI::EO 14222 - IMPLEMENTING THE PRESIDENT'S DOGE COST EFFICIENCY INITIATIVE::EOI NOTICE OF TERMINATION FOR CONVENIENCE	Centers For Disease Control And Prevention	541720	$0	Apr 23, 2024	Jun 29, 2025
75F40119C10101 ↗	BAA FOR NEURODEVELOPMENTAL OUTCOMES IN INFANTS RECEIVING OPIOID-REPLACEMENT PHARMACOTHERAPY FOR NEONATAL OPIOID WITHDRAWAL SYNDROME(NOWS), REFERENCE: BAA- EETWP#31.	Food And Drug Administration	541715	$0	Sep 20, 2019	Aug 6, 2025
75N93024P01130 ↗	EOI::DEFEND THE SPEND::EOI NOTICE OF TERMINATION FOR CONVENIENCE	National Institutes Of Health	541380	$0	Sep 15, 2024	Sep 14, 2025
75D30122F00007 ↗	EOI::EO 14222 - IMPLEMENTING THE PRESIDENT'S DOGE COST EFFICIENCY INITIATIVE::EOI NOTICE OF TERMINATION FOR CONVENIENCE	Centers For Disease Control And Prevention	621399	$0	Sep 28, 2022	Dec 27, 2025
75N92024F00001 ↗	REDS-IV-P DOMESTIC HUBS	National Institutes Of Health	541715	$0	Jun 30, 2024	Jun 29, 2026
80ARC023CA004 ↗	CONTRACT FOR RESEARCH AND DEVELOPMENT WORK TO EXTEND LONGEVITY OF 3D TISSUES AND MICROPHYSIOLOGICAL SYSTEMS FOR MODELING OF ACUTE AND CHRONIC EXPOSURES TO STRESSORS.	National Aeronautics And Space Administration	541715	$0	Oct 31, 2022	Oct 30, 2026
75D30124F00002 ↗	CISA RSV INFANTS STUDY (CONTRIBUTING SITE)	Centers For Disease Control And Prevention	622110	$0	Sep 26, 2024	Sep 25, 2027
75F40120D00039 ↗	EOI::{HHS COST EFFICIENCY INITIATIVE}::EOI. NOTICE OF TERMINATION FOR CONVENIENCE (COMPLETE)	Food And Drug Administration	611710	$0	Sep 29, 2020	—
75N92019D00037 ↗	EO14042 REDS-IV-P DOMESTIC HUBS	National Institutes Of Health	541715	$0	Mar 31, 2019	—
75N92020D00002 ↗	EOI::DEFEND THE SPEND::EOI NOTICE OF TERMINATION FOR CONVENIENCE	National Institutes Of Health	541715	$0	Dec 18, 2019	—
75N92026D00002 ↗	MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - FIELD CENTER (FC)	National Institutes Of Health	541715	$0	Feb 12, 2026	—
HHSD200200723654C ↗	KENYA HIV CARE AND TREATMENT	Centers For Disease Control And Prevention	923120	$0	Sep 27, 2007	Sep 25, 2012
75N93023C00041 ↗	EOI::DEFEND THE SPEND::EOI NOTICE OF TERMINATION FOR CONVENIENCE	National Institutes Of Health	541512	$0	Sep 29, 2023	Mar 6, 2025
75N93020C00059 ↗	TO DEOBLIGATE FY 2020 5TH YEAR FUNDS CHARACTERIZING AND IMPROVING HUMANIZED IMMUNE SYSTEM MOUSE MODELS (IMM-HIS)	National Institutes Of Health	541715	$-0	Sep 29, 2020	Sep 28, 2024
75N92021F00001 ↗	FY26 UDO INITIATIVE - MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) FIELD CENTER (FC) - TASK AREA B EXAM 7	National Institutes Of Health	541715	$-0	May 18, 2021	Mar 28, 2024